MedTrace Logo

IEIK13 For Neurosurgery

NCT04953949 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-11-18

No results posted yet for this study

Summary

The objective of this clinical investigation is to determine the performance and safety profile of NU-MAX® when used as a topical hemostat for oozing bleedings encountered during intracranial procedures, in which control of bleeding by conventional hemostatic techniques is either ineffective or impractical.

Conditions

  • Oozing (Hemorrhage) During Intracranial Procedures

Interventions

DEVICE

NU-MAX®

Topical Hemostat

Sponsors & Collaborators

  • 3-D Matrix Europe SAS

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-06
Primary Completion
2023-08-04
Completion
2023-11-04

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04953949 on ClinicalTrials.gov